Indication
Peptic Ulcer
20 clinical trials
33 products
1 drug
Clinical trial
A Multicenter, Double-blind, Randomized, Parallel, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerStatus: Not yet recruiting, Estimated PCD: 2026-08-30
Product
IlaprazoleProduct
LansoprazoleClinical trial
A Phase I Clinical Trial to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2" in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-05-09
Product
BR6001-1Product
BR6001-2Clinical trial
A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Safety and Efficacy of Tegoprazan 25 mg for the Prevention of Peptic Ulcer Disease in Patients on Continuous Long-term Treatment With NSAIDsStatus: Recruiting, Estimated PCD: 2024-06-01
Product
TegoprazanClinical trial
Study of Non Inferiority of Product Kollagenase ®, Manufactured by Laboratory Cristália When Compared With Iruxol ®, Manufactured by Abbott Laboratory, in the Treatment of Cutaneous UlcersStatus: , Estimated PCD: 2008-02-01
Product
CollagenaseClinical trial
A Post-marketing Surveillance of Pariet Tab. 5 mg to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin, 100 mg or Less Daily, Administration in Korean Patients With a History of Gastric and Duodenal UlcerStatus: Completed, Estimated PCD: 2022-09-22
Product
ParietClinical trial
A Multi-center, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of LXI-15028 Compared to Lansoprazole in the Treatment of Duodenal Ulcer in Chinese Patients for up to 6 WeeksStatus: Completed, Estimated PCD: 2022-09-28
Product
HIP0612Product
HPP2202Product
RLD2204Product
HPP2201Product
LXI-15028Clinical trial
A Multicenter, Randomized, Double-blind, Active-controlled, Phase III Study to Evaluate the Efficacy and Safety of HIP0612 in Patients With Gastric UlcerStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Product
BR6002AClinical trial
An Open-label, Randomized, Fed, Single-dose, 2-sequence, 4-period, Full Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-09-12
Product
BR6002Product
D961HClinical trial
An Open Label, Parallel Group, Multi-centre, Phase III Study to Assess the Efficacy and Safety of D961H for the Maintenance Therapy Following Initial Treatment in Japanese Paediatric Patients With Reflux Esophagitis and for the Prevention of Recurrence of Gastric Ulcer or Duodenal Ulcer in Japanese Paediatric Patients Treated With Non-steroidal Anti-inflammatory Drugs or Low-dose AspirinStatus: Completed, Estimated PCD: 2022-12-27
Clinical trial
An Open-label, Randomized, Fasting, Single-dose, 2-sequence, 4-period, Full Replicated Crossover Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2023-08-24
Product
BR6002BClinical trial
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology (CGDP) in Schoolchildren in the Primary Health Care System.Status: Active (not recruiting), Estimated PCD: 2025-12-30
Product
Enteral oxygen therapyClinical trial
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyStatus: Recruiting, Estimated PCD: 2023-12-02
Product
EsomeprazoleProduct
AmoxicillinProduct
BismuthProduct
ClarithromycinClinical trial
Efficacy of Vonoprazan Versus Intravenous Proton Pump Inhibitors for Prevention of Rebleeding in High Risk Peptic Ulcers Bleeding After Successful Endoscopic HemostasisStatus: Completed, Estimated PCD: 2022-12-01
Product
VonoprazanProduct
PPIs IV infusionClinical trial
Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.Status: Recruiting, Estimated PCD: 2022-11-03
Product
ciprofolClinical trial
A Multicenter, Parallel, Double-blind, Randomized, Active-controlled, Non-inferiority, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 Treatment in the Prevention of (NSAIDs)-Induced Peptic UlcersStatus: Not yet recruiting, Estimated PCD: 2027-08-01
Product
JP-1366Product
LanstonClinical trial
The Incidences Of Hypoxia And Severe Hypoxia During Gastroenterological Endoscope Procedures Sedated With Ciprofol Compared With Propofol In Overweight Or Obesity Adults Patients, A Multicenter, Randomized, Controlled TrialStatus: Completed, Estimated PCD: 2023-08-15
Product
CiprofolProduct
PropofolClinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Completed, Estimated PCD: 2021-12-20
Product
TetracyclineProduct
FurazolidoneClinical trial
Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2018-12-01
Product
ALBISDrug
VarlilumabClinical trial
A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of NL003 in Subject With Critical Limb Ischemia（Rutherford 5）Status: Completed, Estimated PCD: 2023-12-23
Product
NL003Clinical trial
A Multi-center, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic UlcerStatus: Completed, Estimated PCD: 2023-11-27
Product
DWP14012